1-2 of 2
Lidwine Tick
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long term follow-up and results of retreatement after obinutuzumab-venetoclax in first-line CLL patients with coexisting conditions

Free
Mark-David Levin, Sabina Kersting, Kazem Nasserinejad, Johan DObber, Clemens Mellink, Anne-Marie Van Der Kevie-Kersemaekers, Ludo Evers, Fransien De Boer, Harry Koene, John Schreurs, Marjolein van der Klift, Gerjo Velders, Ellen van der Spek, Hanneke van der Straaten, Mels Hoogendoorn, Michel van Gelder, Ward Posthuma, Hein Visser, Ilse Houtenbos, Cecile Idink, Djamila Issa, Henk van Zaanen, Hendrik Veelken, Henirette Levenga, Lidwine Tick, Wim Terpstra, Sanne Tonino, Julie Dubois, Arnon Kater
Journal: Blood
Blood (2025) 146 (Supplement 1): 3897.
https://doi.org/10.1182/blood-2025-3897
Published: 2025
Journal Articles

Improved Efficacy with Response- and MRD-Guided Ibrutinib-Obinutuzumab (IO) Intensification after Ibrutinib-Venetoclax (IV) in First Line Chronic Lymphocytic Leukemia (CLL) Patients: Primary Analysis of the HOVON 158/Next STEP Phase 2 Trial

Free
Mark-David Levin, Sabina Kersting, Julie Dubois, Bronno van der Holt, Caspar da Cunha-Bang, Doreen te Raa, Cecile Idink, Fransien De Boer, Jolanda Droogendijk, Koen de Heer, Leonie van der Burg, Marten R. Nijziel, Lidwine Tick, Henriettte Levenga, Matthijs Silbermann, Inge Ludwig, Aart Beeker, Mar Bellido, Anne-Marie Van Der Kevie-Kersemaekers, Clemens Mellink, Ine Meulendijks, Sjoerd Zoun-van den Dool, Martine Abrahamse-Testroote, Gerben Zwezerijnen, Carsten Utoft Niemann, Arnon P. Kater
Journal: Blood
Blood (2024) 144 (Supplement 1): 1013.
https://doi.org/10.1182/blood-2024-207452
Published: 2024